<DOC>
	<DOCNO>NCT01417767</DOCNO>
	<brief_summary>The purpose study compare efficacy CHG regimen ( low-dose cytarabine , homoharringtonine G-CSF priming ) decitabine treatment higher-risk myelodysplastic syndrome ( MDS ) .</brief_summary>
	<brief_title>Efficacy Study CHG Regimen v Decitabine Treat Higher-risk MDS</brief_title>
	<detailed_description>Patients higher-risk myelodysplastic syndrome ( MDS ) survival rate 0.4 1.2 year well high risk disease progress acute myeloid leukemia ( AML ) . The treatment curative potential allogeneic stem cell transplantation . However , majority patient , treatment applicable , mainly due age recipient comorbid condition . Low-dose chemotherapy CHG regimen ( low-dose cytarabine , homoharringtonine G-CSF priming ) use treat higher-risk MDS China achieve high response rate . Hypomethylating agent 5-aza-2'-deoxycytidine ( decitabine ) nucleoside analog covalently bind DNA methyltransferases , irreversibly inhibit function , lead progressive loss methylation reversal gene silence . The purpose study compare efficacy safety CHG regimen Decitabine higher-risk MDS .</detailed_description>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Decitabine</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<mesh_term>Homoharringtonine</mesh_term>
	<criteria>Age ring 16 80 year ; diagnosis higherrisk MDS ( with≥ 5 % blast bone marrow ) ; performance status 03 accord Eastern Cooperative Oncology Group ( ECOG ) ; evidence severe concurrent cardiac , pulmonary , neurologic , metabolic disease ; adequate hepatic ( serum bilirubin level &lt; 2×upper normal limit ) renal ( serum creatinine &lt; 2×upper normal limit ) function test . Female pregnancy ; performance 45 accord ECOG score ; HIV positive ; uncontrolled severe fungal infection tuberculosis ; progressive malignant disease .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>myelodysplastic syndrome</keyword>
	<keyword>Decitabine</keyword>
	<keyword>homoharringtonine</keyword>
	<keyword>cytarabine</keyword>
	<keyword>G-CSF</keyword>
</DOC>